| scholarly article | Q13442814 |
| P2093 | author name string | A Forsberg | |
| B Björkstén | |||
| M C Jenmalm | |||
| T R Abrahamsson | |||
| P2860 | cites work | Intestinal microflora of Estonian and Swedish infants | Q47778356 |
| Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice | Q48318531 | ||
| A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial | Q50622653 | ||
| Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferon-gamma and breast milk transforming growth factor-beta and immunoglobin A detection. | Q50627720 | ||
| Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. | Q51647156 | ||
| Probiotics during weaning reduce the incidence of eczema. | Q51760401 | ||
| Cytokine responses to allergens during the first 2 years of life in Estonian and Swedish children. | Q51982890 | ||
| Transcriptional characteristics of CD4+ T cells in multiple sclerosis: relative lack of suppressive populations in blood. | Q54410992 | ||
| Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. | Q54746716 | ||
| Effects ofLactobacillusGG treatment during pregnancy on the development of fetal antigen-specific immune responses | Q57819948 | ||
| Altered early infant gut microbiota in children developing allergy up to 5 years of age | Q58590854 | ||
| Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma | Q59054619 | ||
| Hay fever, hygiene, and household size | Q24674856 | ||
| Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial | Q28211907 | ||
| Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation | Q33356616 | ||
| Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders | Q33719638 | ||
| Allergy development and the intestinal microflora during the first year of life | Q34094058 | ||
| Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin | Q34424372 | ||
| IL-35-mediated induction of a potent regulatory T cell population. | Q34432872 | ||
| Human CD4+ CD25+ Foxp3+ regulatory T cells do not constitutively express IL-35. | Q34599678 | ||
| Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis | Q37060816 | ||
| Childhood immune maturation and allergy development: regulation by maternal immunity and microbial exposure. | Q37897267 | ||
| Timing of allergy-preventive and immunomodulatory dietary interventions - are prenatal, perinatal or postnatal strategies optimal? | Q38081992 | ||
| Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial | Q38372709 | ||
| Probiotic effects on T-cell maturation in infants during weaning | Q39640984 | ||
| A Th1/Th2-associated chemokine imbalance during infancy in children developing eczema, wheeze and sensitization. | Q39723114 | ||
| Identification and characterization of IL-10/IFN-gamma-producing effector-like T cells with regulatory function in human blood | Q42572213 | ||
| Immune responses to birch in young children during their first 7 years of life | Q44373087 | ||
| Utility of the housekeeping genes 18S rRNA, beta-actin and glyceraldehyde-3-phosphate-dehydrogenase for normalization in real-time quantitative reverse transcriptase-polymerase chain reaction analysis of gene expression in human T lymphocytes | Q44925185 | ||
| Epigenetic regulation in murine offspring as a novel mechanism for transmaternal asthma protection induced by microbes | Q45324302 | ||
| P433 | issue | 4 | |
| P921 | main subject | Lactobacillus reuteri | Q597078 |
| infancy stage | Q49257364 | ||
| P304 | page(s) | 434-442 | |
| P577 | publication date | 2013-04-01 | |
| P1433 | published in | Clinical & Experimental Allergy | Q5133747 |
| P1476 | title | Pre- and post-natal Lactobacillus reuteri supplementation decreases allergen responsiveness in infancy. | |
| P478 | volume | 43 |
| Q101133206 | Changes in peripheral immune populations during pregnancy and modulation by probiotics and ω-3 fatty acids |
| Q38914580 | Colonization of germ-free mice with a mixture of three lactobacillus strains enhances the integrity of gut mucosa and ameliorates allergic sensitization |
| Q34719711 | Customized nutritional enhancement for pregnant women appears to lower incidence of certain common maternal and neonatal complications: an observational study |
| Q36064757 | Early-Life Events, Including Mode of Delivery and Type of Feeding, Siblings and Gender, Shape the Developing Gut Microbiota |
| Q51032519 | Effects of Gender and Age on Immune Responses of Human Peripheral Blood Mononuclear Cells to Probiotics: A Large Scale Pilot Study. |
| Q36171857 | Expression and Purification of the Uropathogenic Escherichia coli PapG Protein and its Surface Absorption on Lactobacillus reuteri: Implications for Surface Display System Vaccines. |
| Q91697117 | Extremely Preterm Infants Have Significant Alterations in Their Conventional T Cell Compartment during the First Weeks of Life |
| Q34007290 | From prediction to function using evolutionary genomics: human-specific ecotypes of Lactobacillus reuteri have diverse probiotic functions |
| Q35658212 | Hypolipidemic effects and safety of Lactobacillus reuteri 263 in a hamster model of hyperlipidemia |
| Q41510872 | Lower anti-echovirus antibody responses in children presenting to hospital with asthma exacerbations. |
| Q50787321 | No effect of probiotics on respiratory allergies: a seven-year follow-up of a randomized controlled trial in infancy. |
| Q36216412 | Planting the seed: Origins, composition, and postnatal health significance of the fetal gastrointestinal microbiota |
| Q33853177 | Pre- and postnatal administration of Lactobacillus reuteri decreases TLR2 responses in infants |
| Q38807785 | Pre- and probiotics for allergy prevention: time to revisit recommendations? |
| Q48092790 | Pregnancy modulates the allergen-induced cytokine production differently in allergic and non-allergic women. |
| Q38268271 | Probiotics and pregnancy. |
| Q35907513 | Probiotics for treatment and primary prevention of allergic diseases and asthma: looking back and moving forward |
| Q58439220 | Recent advances in food allergy |
| Q88007468 | Regular consumption of Lactobacillus reuteri-containing lozenges reduces pregnancy gingivitis: an RCT |
| Q28088606 | The Microbiome and Sustainable Healthcare |
| Q35044607 | The composition of the gut microbiota throughout life, with an emphasis on early life. |
| Q53139370 | The early administration of Lactobacillus reuteri DSM 17938 controls regurgitation episodes in full-term breastfed infants. |
| Q35158619 | The gut microbiota and its role in the development of allergic disease: a wider perspective |
| Q26775415 | The microbiome of the built environment and mental health |
| Q34309689 | The overarching influence of the gut microbiome on end-organ function: the role of live probiotic cultures |
Search more.